phase readout
saveNCT07550673: Upadacitinib Versus Infliximab as Second-Line Treatment for Acute Severe Ulcerative Colitis（UPRISE）
RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: Xijing Hospital of Digestive Diseases. Phase: PHASE4. Conditions: Acute Severe Ulcerative Colitis
view source ↗
comments(0)
5-min edit window · permanent after that